BiondVax Pharmaceuticals Ltd. (BVXV)

NASDAQ: BVXV · IEX Real-Time Price · USD
1.48 -0.10 (-6.33%)
Jan 21, 2022 4:00 PM EST - Market closed
Market Cap27.34M
Revenue (ttm)n/a
Net Income (ttm)-13.54M
Shares Out18.48M
EPS (ttm)-2.30
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume516,017
Open1.54
Previous Close1.58
Day's Range1.46 - 1.65
52-Week Range1.36 - 7.22
Beta2.34
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BVXV

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and related illnesses in Israel. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

IndustryPharmaceuticals
Founded2003
CEORon Babecoff
Employees21
Stock ExchangeNASDAQ
Ticker SymbolBVXV
Full Company Profile

Financial Performance

Financial numbers in millions ILSFinancial Statements

News

BiondVax to Present at H.C. Wainwright Bioconnect Virtual Conference

JERUSALEM, Jan. 10, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the pr...

1 week ago - PRNewsWire

Aegis Capital Corp. Acted as Sole Bookrunner on a $9.8 Million Underwritten Public Offering of ADSs for BiondVax Phar...

NEW YORK, NY / ACCESSWIRE / January 3, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on a $9.8 Million Underwritten Public Offering of ADSs for BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV).

2 weeks ago - Accesswire

BiondVax Announces Successful Closing of $9.8 million Follow-on Underwritten Offering of ADSs Including Exercise of t...

JERUSALEM, Dec. 29, 2021  /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the p...

3 weeks ago - PRNewsWire

Hot Penny Stocks to Watch During the Santa Claus Rally

Are these penny stocks on your watchlist during the Santa Claus rally? The post Hot Penny Stocks to Watch During the Santa Claus Rally appeared first on Penny Stocks to Buy, Picks, News and Information ...

Other symbols:KNDIRELI
3 weeks ago - PennyStocks

Former CFO of GSK's Global Vaccines Business Mr. Jay Green Joins BiondVax's Board of Directors

JERUSALEM, Dec. 27, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the pr...

Other symbols:GSK
3 weeks ago - PRNewsWire

BiondVax Announces Pricing of $9.0 million Follow-on Underwritten Offering of American Depositary Shares

JERUSALEM, Dec. 27, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the pr...

3 weeks ago - PRNewsWire

BiondVax Announces Proposed Underwritten Public Offering of American Depositary Shares

JERUSALEM, Dec. 23, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the pr...

4 weeks ago - PRNewsWire

Why BiondVax Shares Are Soaring Today

BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) is trading higher Wednesday after the company announced it signed definitive agreements for the development and commercialization of nanosized COVID-19 antibo...

4 weeks ago - Benzinga

BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pharma Soaring

Biondvax Pharmaceuticals (BVXV) stock is on the rise Wednesday thanks to some positive news concerning its Covid-19 antibodies. The post BVXV Stock Alert: The Covid-19 Antibody News Sending BiondVax Pha...

4 weeks ago - InvestorPlace

Hot Penny Stocks to Buy Now? 3 For Your New Years Watchlist

Are these penny stocks on your end of 2021 watchlist? The post Hot Penny Stocks to Buy Now?

Other symbols:AVCTRCAT
4 weeks ago - PennyStocks

BiondVax signs definitive agreements for development and commercialization of innovative nanosized COVID-19 antibody ...

JERUSALEM, Dec. 22, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the pr...

4 weeks ago - PRNewsWire

BiondVax announces Third Quarter 2021 Financial Results and Provides Business Update

JERUSALEM, Nov. 30, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment...

1 month ago - PRNewsWire

BiondVax Announces Notice of Annual General Meeting of Shareholders and Provides a Business Update

JERUSALEM, Israel, Nov. 24, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and t...

1 month ago - PRNewsWire

BiondVax to Present at H.C. Wainwright 7th Annual Israel Conference

JERUSALEM, Nov. 15, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment...

2 months ago - PRNewsWire

BiondVax advances its growth strategy towards a new pipeline based on innovative VHH antibodies

JERUSALEM, Oct. 19, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), which focuses on developing, manufacturing and commercializing innovative products for the prevention and treatment...

3 months ago - PRNewsWire

BiondVax Announces Second Quarter 2021 Financial Results and Provides Business Update

JERUSALEM, Aug. 26, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

4 months ago - PRNewsWire

BiondVax Announces First Quarter 2021 Financial Results and Provides Business Update

JERUSALEM, June 23, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

6 months ago - PRNewsWire

BiondVax Announces Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

JERUSALEM, May 13, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pre...

8 months ago - PRNewsWire

Letter from BiondVax's New CEO to Shareholders

JERUSALEM, March 23, 2021 /PRNewswire/ -- Dear Shareholders, After many years of pharmaceutical leadership positions in the US and Europe, I jumped at the opportunity to return to my roots in Israel to ...

9 months ago - PRNewsWire

BiondVax Announces Exercise in Full of Underwriter's Over-Allotment Option in Follow-on Offering

JERUSALEM, Feb. 10, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

11 months ago - PRNewsWire

BiondVax Announces Closing of $12.1 Million Follow-on Underwritten Offering

JERUSALEM, Israel, Feb. 2, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for...

11 months ago - PRNewsWire

BiondVax Announces Pricing of $12.1 Million Follow-on Underwritten Offering of American Depositary Shares

JERUSALEM, Jan. 29, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

11 months ago - PRNewsWire

BiondVax Announces Launch of Proposed Underwritten Follow-on Offering of American Depositary Shares

JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

11 months ago - PRNewsWire

BiondVax Announces Third Quarter 2020 Financial Results & Business Update

JERUSALEM, Jan. 28, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on developing, manufacturing and ultimately commercializing products for the pr...

11 months ago - PRNewsWire

BiondVax Announces Appointment of Amir Reichman as New CEO

JERUSALEM, Jan. 21, 2021 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on development and manufacturing of products for the prevention and treatment o...

1 year ago - PRNewsWire